Statistics for Tenaya Therapeutics, (id:8084 TNYA)
Valuation metrics
Market cap
188.54M
Enterprise value
106.19M
Trailing P/E (ttm)
-1.42
Forward P/E
-1.92
PEG ratio
-1.92
Price/Sales (ttm)
Price/Book (mrq)
1.67
Enterprise Value/Revenue
Enterprise Value/EBITDA
-0.93
Overview
Shares outstanding
79.22M
Float
54.54M
Shares short
5.24M
% Held by insiders
0.01%
% Held by institutions
0.74%
Average volume (10 days)
4.45M
Average volume (90 days)
Price summary
52-Week low
1.61
52-Week high
7.01
52-Week change
20.17%
Beta
2.35
50-Day moving average
2.01
200-Day moving average
3.55
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-45.94%
Return on equity
-84.49%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-114,182,000.00
Net income to common (ttm)
-117,228,000.00
Diluted EPS (ttm)
-1.44
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
79.47M
Total cash per share (mrq)
1.00
Total debt (mrq)
14.54M
Total Debt/Equity (mrq)
12.91
Current ratio (mrq)
527.50%
Book value per share (mrq)
1.42
Cash flow
Cash flow statement
-94,037,000.00
Levered free cash flow (LFCF)
-56,520,752.00